EGF and neoplasm: In pancreatic cancer cells (BxPC-3), inhibition of the epidermal growth factor (EGF)/extracellular signal-regulated kinase (ERK) and EGF/AKT pathways has also been observed [66], confirming its ability to affect growth receptors and tumour proliferation.